Adapthealth Corp. (AHCO) closed at $7.80 on November 11, 2026, up 1.0% from the previous close, on volume of 1,974,488 shares (30-day average 2,405,558).
Data as of November 11, 2026.
11-Nov-2026
AdaptHealth Corp. to Participate in Upcoming Investor Conference
Business Wire (Wed, 4-Nov 4:05 PM ET)
Market Chameleon (Tue, 3-Nov 3:12 AM ET)
AdaptHealth Corp. Announces Third Quarter 2026 Results
Business Wire (Tue, 3-Nov 7:00 AM ET)
AdaptHealth Corp. Announces Third Quarter 2026 Earnings Release Date and Conference Call
Business Wire (Wed, 21-Oct 8:00 AM ET)
AdaptHealth To Participate in Upcoming Investor Conferences
Business Wire (Fri, 11-Sep 1:00 PM ET)
AdaptHealth Appoints Harriss Currie as Chief Financial Officer
Business Wire (Tue, 8-Sep 4:00 PM ET)
ReDream Brands Launches as the Leading Direct-to-Consumer Platform for Sleep Apnea and Sleep Health
PRNewswire (Mon, 17-Aug 9:00 AM ET)
Globe Newswire (Fri, 14-Aug 7:44 PM ET)
AdaptHealth Corp. (AHCO) Securities Investigation Notice - Levi & Korsinsky
PRNewswire (Wed, 12-Aug 10:09 AM ET)
Market Chameleon (Tue, 11-Aug 3:36 AM ET)
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
Adapthealth Corp. trades on the NASDAQ stock market under the symbol AHCO.
As of November 11, 2026, AHCO stock price climbed to $7.80 with 1,974,488 million shares trading.
AHCO has a beta of -1.99, meaning it tends to be less sensitive to market movements. AHCO has a correlation of 0.09 to the broad based SPY ETF.
AHCO has a market cap of $1.04 billion. This is considered a Small Cap stock.
Last quarter Adapthealth Corp. reported $746 million in Revenue and $.12 earnings per share. This beat revenue expectation by $20 million and exceeded earnings estimates by $.14.
In the last 3 years, AHCO traded as high as $13.43 and as low as $5.21.
The top ETF exchange traded funds that AHCO belongs to (by Net Assets): IJR, IWM, VTI, DFSV, DFAT.
AHCO has underperformed the market in the last year with a return of -18.2%, while SPY returned +12.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in AHCO shares. However, AHCO has outperformed the market in the last 3 month and 2 week periods, returning +38.1% and +29.4%, while SPY returned -1.1% and -1.6%, respectively. This indicates AHCO has been having a stronger performance recently.
AHCO support price is $7.48 and resistance is $7.97 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AHCO shares will trade within this expected range on the day.